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TRYPANOSOMA CRUZI: EXPRESSION OF ANTIGENIC CQMPONENT 5 AMONG 35 
LABORATORY CLONES OBTAINED FROM 18 DIFFERENT ISOZYMIC VARIANTS 
S U M M A R Y  
Two monoclonal antibodies anti-component 5 of Trypanosoma cruzi (1-35/115 
and II-190/30) were tested in IFA and ELISA respectively against 35 T. cruzï la- 
boratory clones. Among the 35 clones tested, 18 different isozyme patterns were 
detected. All clones were recognized by both monoclonal antibodies except one 
clone which did not react with II-190/30. These results support the universal ex- 
pression of specific component 5 within the taxon T. cruzi. 
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I N T R O D U C T I O N  
Trgpanosoma cruzï, the causative agent of by serologic techniques since circulating levels 
Chagas’ disease, infects 24 million people in of parasites are too low. However, techniques 
American. It displays a large heterogeneity used in standard serology are not specific 
in both morphology and biologys: for example, enough to discriminate Leishmania and T. c d  
differences are observed in virulence, tissue tro- infections 2JO. Furthermore, several mixed in- 
Pism, pathogenicity, drug resistance and anti- . fection areas have been found in Central and 
gen composition. South America%% Thus, for diagnostic purpo- 
T. cruzi stocks have been characterized ta- 
xonomically by means of isoenzyme studies. 
Analysis of zymograms enabled MILES et h1.1W 
and READY & MILES16 to distinguish three 
major groups of isozymic strains which were 
called “qymodemes”. An extensive i s o w e  stu- 
dy on 121 stocks of T. cruziz, isolated from va- 
rious regions of South and Central America, 
described 43 isozyme variants which exhibited 
large genetic variability and did not fall into 
the 3 main clusters that had been proposed ini- 
tially 13,14.16. 
Diagnosis of Chagas’ disease during inde- 
terminate and chronic phases is only possible 
ses, for an effective immunological approach 
to Chagas’ disease, it would be important to 
demonstrate the presence of universal antigens 
among the taxon T. cruzi. 
Comparative studies of epimastigote cultu- 
res of T. cruzï and other Tqypanosomatii 
have demonstrated the existence of a T. cruzi 
specific antigenic component: component 5 1. 
This antigen exhibits several characteristic fea- 
tures. It possesses a great level of immunoge- 
nicity in natural4 or experimental infections as 
in immunization experiments 1 and has been 
found at the surface of epimastigotes and 
bloodstream trypomastigotes 9. Three murine. 
monoclonal antibodies against component 5 of 
(1) ORSTOM - IBBA, Casilla 8714, La Pas, Bolivia. 
(2) IBBA, c/o Embajada de Francia, Casilla 824, La Paz Bolivia. 
(3) Universite des Sciences et Techniques de Lille I, Laboratoire de Chimie Biologique associ6 au CN&9 (LA 217) - IBBA. 
c/o Embajada de Francia, Casilla 824, La Paz, Bolivia. 
(4) C.IB.P., Institut Pasteur de Lille, 15 rue Camille GuBrin. 59019 Lille France. 
(5) Institut Pasteur de Paris - IBBA. c/o Embajada de Francia, Casilla 824, La Pa!??, Bolivia. 
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T. cruzi have been purified and characterized 15. 
Monoclonal antibody 1-35/115 has been shown 
to bind the epimastigote cell surface (immuno- 
fluorescence study) and monoclonal antibodies 
II-190/30 and II-160118 to bind internal organel- 
les. Immunoprecipitation of T. cruzì iodinated 
soluble antigen with these monoclonal anti- 
bodies, followed by polyacrylamide gel analysis, 
has led to the identification of four molecules 
whose respective molecular weights are: 72 kD, 
51 kD, 43 kD and 24 kD15. These proteins were 
not recognized with the same intensity by the 
three monoclonal antibodies. Finally, 96.6% 
of chronic chagasic patient sera have been de- 
tected by competitive enzyme immunoassay us- 
ing anti-component 5 monoclonal antibody (II- 
190/30). This test is still in evaluation in seve- 
ral laboratories in South America, With W.H.O. 
grant support. 
Here, we evaluate T. cruzi component 5 
with 2 monoclonal antibodies (1-35/115 and II- 
190/30) in the taxon T. c d .  Among 35 clones 
tested, 18 isoenzyme patterns were detected 
(TIBAYRENC et al. classification, 251, and re- 
present a large proportion of the genotypes 
classified .up to now. 
'* 
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MATERIALS AND METHODS 
1 - Parasites: 
Parasites were grown in LIT medium. 
Twenty T. crwi stocks representing 20 differ- 
ent isozymic strains classified according to 
TIBAYRENC et al.% have been cloned by mi- 
cromanipulation; 35 laboratory clones were so 
obtained. The original stocks were isolated 
from mammals or bug vectors from various 
geographic origins (see Table 1). Control stocks . were Leismania mexicana amazc~lensis ('WHO 
IFLA/BR/67/PH-8), Leisbania brasìliensis br% 
ziliensis (WHO MHOM/BR/75JM-29041, 6 Leish. 
mania braziliensis braziliensis Bolivian stocks 7 
and Trypanosoma rangeli RBG strain. # 
2 - Isoenzyme analysis of T. cruzì clones: 
Isoenzyme analysis of the clones was per- 
formed using 9 enzyme systems: glucose 6 phos- 
phate dehydrogenase (E. C. 1.1.1.491, glucose 6 
phosphate isomerase (E. C. 5.1.3.91, glutamate 
dehydrogenase NADP+ (E. C. 1 .4.1.4), isocitra- i 
te dehydrogenase (E.C.1.1.1.421, malate dehy- 
drogenase (E. C. 1.1.1.371, malate dehydrogena- 
se (oxalo-acetate decarboxylating) NADP+ or 
malic enzyme (E. C .  1.1.1.40), phosphoglucomu- 
tase (E.C.5.4.2.2, formerly E.C.2.7.5.11, phos- 
phogluconate dehydrogenase (E. C .  1.1.1.44) 
and mannose phosphate isomerase (E.C.5.3.1.8). 
Methods were described previously 24. 
3 - IFA - indirect fluorescent antibody test: 
Following the technique described by 
OROZCO et al.fi, this test was carried out on 
epimastigote forms in their initial stationary 
phase. The monoclonal a n t i b e  (Mc Ab 1-351 
115) was used. The conjugate was fluorescein 
conjugated anti-mice IgG (HSL) (Institut Pas- 
teur Production, Paris, France). All assays were 
performed in duplicate. 
4 -ELISA - Enzyme Linked Immunosor- 
Epimastigote parasites from the initial sta- 
tionary phase were washed 3 times in Hanks- 
Wallace solution, resuspended in NaCl 9% 
(100x106 p/100 1.111, sonicated and centrifuged at 
26,000 g for one hour at 4°C. Subsequent steps 
have been described previously 3. hxrified Mc 
Ab II-190/30 was labelled with alkaline phos- 
phataselz. All assays were performed in dupli- 
cate. Extinction values were measured at 405 
bent Assay: 
nm. 
RESULTS 
1 - Isozymic variability of T. cru& cloned 
strains: 
Laboratory clones, compared to their ori- 
ginal stocks on the basis of isozyme patterns, 
appeared to. be similar in all cases, except one 
strain with isoenzyme pattern number 19. The 
original stocks differed for glucose 6 phosphate 
isomerase (2 bands instead of one observed in 
4 clones obtained from this stmk). GPI is a di- 
meric enzyme and the 2 bands obtained for the 
original stock were probably the result of a 
mixed population. 
2 - Expression of component 5 in clones of 
T. cru!& 
All results are summarized in Table 1. Tes- 
ted clones were isolated from different mam- 
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T A B L E  I 
Expression of antigenic component 5 in T. cru!d isozymic clones 
Number of Country of Source of No. of ' Mc Ab recognition of Component 5 
T. Cros O r i g i n  isolates a b 
isozyme strains P A  ELISA 
of original Mc Ab 1-35/115 MC Ab II-190/30 
S t o c k s  C 
Extinction values 
1 Chile Human 
4 French Wild 
Guiana mammal ,J 
4 
11 
d 
French Triatoma 
Guiana 
Bolivia HUman 
O 
1 Bolivia Wild 
mammal 
3 Bolivia Triatoma 
infestans 
d 
3 Bolivfa Triatoma 
7 Brazil HUman 
1 Brazil Wild 
mammal 
43 
3 
5 (2 clones) 
11 
1 (4 clonesi 
10 (3 clones) 
16 
19 (5 clones) 
39 
39 
28 
32 
9 
32 
25 (3 clones) 
not classified (2 clones) 
17 
30 (2 clones) 
34 
35 
36 
+ + + + 
+ 
+ + + 
-i- 
-i- + 
+ + + 
+ + + + + + + 
0.43 
1 .M) 
0.35 
0.22, 0.70 
0.73, 0.94, 0.95, 1.02 
0.95, 1.12, 1.60 
1.47 
0.36, 0.43, 0.82. 1.16, 1.a 
1.01 
0.72 
0.26 
0.21 
0.31 
O .o8 
8.75, 1.06, 1.28 
0.26. 1.18 
1.57 
0.9, 1.04 
1.23 
1.10 
1.25 
----------------_-_------------------- 
Control 
strains 
L. m. 8. Panama, - - 0.03 
L. b. b. 6 Bolivia 4 Human - - 0.01, 0.02. 0.03, 0.06 
2 sandfly - - 0.02, 0.07 
1 Brazil HUman - - 0.03 
- 0.03 , T. rangeu Venezuela Dog - 
a - The isozymic strains were classified according to TIBAYl7,ENC et al.". 
b - Mc Ab 1-35/115 was diluted at 1/10 and 1/25. 
C - The extinction values of ELISA were from duplicate assays; the limit extinction value was 0.096 determined 88 
d - Triatoma other than T. infestans. 
Among 35 T. Crnd clones tested, 18 M e  
rent isozyme patterns were observed. 
m + 3 X (standard deviation) of the 9 control strains. 
mals and vectors. Only one Bolivian clone iso- 
lated from Triatoma infestans (isozymic strain 
No. 32) produced a negative result in,.ELISA 
with Mc Ab 11-190/30. All other clones were 
recognized by both Mc Ab I-35/115 and Mc Ab 
II-190/30 tested, respectively, in IFA and ELI- 
SA. Extinction values obtained in ELISA, which 
ranged from 0.08 to 1.57, demonstrate a high le- 
vel of heterogeneity. IFA controls consisting of 
a L. m. amazonensis strain, 7 L. b. bradiemis 
strains and a Te rangeli strain were negative. 
The limit extinction value of ELISA was deter- 
mined to be m -f- 3 times the standard devia- 
tion of the 9 control strains: 0.0338 $- (3 x 
0.027) = 0.096. 
mxmssioN 
1 - Clonal diversity in a single isolate of T. 
C111zi: 
Our data support the presence of a mixed 
population in one T. cruzi human isolate. 'This 
confirms genetic heterogeneitg of singIe T, cN- 
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zi isolates. Similar findings based on isoenzy- 
me patterns have been reported previously for 
natural populations of T. cruzi isolated from 
both triatomine bug vectors 23 and humans 5. 
All these results emphasize the usefulness of 
cloning before expérimental studies of T. cruzi 
are conducted 1, as recommended by DVORAK 
et al. 8. 
2 - Specific antigens of T. cruzï and their diag- 
WHO (1975) 26 recommends the use of spe 
cific antigens in the diagnosis of Chagas' disea- 
se. Candidate proteins must be expressed in 
all isoenzyme variants and must be absent in 
Leishmania and T. rangeli strains. 
Several antigens have been proposed and 
warrant further research. 
nostic application: 
a) The 90 kD glycoprotein antigen semi-pu- 
rified by lectin affinity chromatography was 
tested in ELISA system 18. This test is quite sen- 
sitive but reacts with sera of patients infected 
with Leishmania. The authors suggest that pu- 
rification of this antigen is necessary. 
b) The 25 kD glycoproteirl. has been propos- 
ed as specific to T. cruzi, but was only tested 
on 8 T. cruzi strains17. This protein was not 
detected on either T. rangeli or Leishmanial'. 
96.5% of chagasic patients sera were positive 
in immunoprecipitation against this purified 
protein, and all 23 Leishmania human sera were 
negative in this test 17. However, no information 
was given concerning the possible crosse@-reac- 
tions of these control sera in standard serology 
for Chagas' disease. 
cl A 72 kD surface glycoprotein isolated 
from both epimastigote and metacyclic trypo- 
mastigotes was purified by monoclonal affini- 
ty chromatography B.  Monoclonal antibodies &- 
retted against various epitopes of 72 kD glyco- 
protein have been obtained. These epitopes 
were shown to be strain- or species8pecific 6, 
W 9 .  Some of these monoclonal antibodies are 
good candidates for use in Chagas' diagnosis. 
d) Lastly, our results support the universal 
expression of T. cruzi component 5 among va- 
ried set of T. cruzi genotypes. Indeed, 18 isozy- 
me variants from different regions and isolate 
origins were recognized by Mc Ab I-35/115. 
However, it is worth noting that quantitative 
differences were observed in the recognition 
of the clones using the second Mc Ab II-190/30 
in ELISA. This could be due to different levels 
of expression of the epitope recognized by Mc 
Ab II-190/30. These quantitative differences 
seem independent of genotype: for genotype 19 
we tested 5 clones which range from 0.36 to 
1.48, and as great a quantitative difference is 
observed for genotype 1 (4 clones tested) and 
genotype 5 (2 clones tested). Both Mc Ab used 
in this work are directed against a 72 SrD gly- 
coprotein (component 51, and the identity of 
this antigen with the 72 kD glycoprotein of 
SNARY et a1.a has been suggestedrs. Never- 
theless, further studies are required to show 
the identity of monoclonal antibodies against 
the 72 kD protein, and others against compo- 
nent 5. Finally, a specific test using the Mc Ab 
II-190/30 has been proposed 12. Our results con- 
firm the utility of this test in specific diagnosis, 
but appropriate controls of Leishmmb sera . 
must be tested to ascertain its application in 
areas with mixed leishmanial and chagasic in- 
fections. 
RESUMO 
Trypanosoma cruzi: Express50 do componente 
antig8nico 5 entre 35 clones de laboratório ob- 
tidos de 18 vadantes is0e-m. 
Dois anticorpos monoclonais anticompo- 
nente 5 de Trypanosoma c d  (1-35/115 e II- 
190/30) foram testados respectivamente em IFA 
e ELISA sobre 35 clones de T. cruzi-isolados no 
laborat6rio. Entre estes 35 clones testados, 18 
perfis isoenzimicos diferentes puderam ser de- 
tectados. Todos os clones foram reconhecidos 
exceto um clone que não reagiu com o anticor 
PO monoclonal II-190/30. Estes resultados sãu 
a favor da expressão constante do componente 
5 no seio do tax6n T. onrid. 
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